SureTrader
Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

What you are asking about would require a

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
XenaLives Member Profile
Member Level 
Followed By 271
Posts 28,761
Boards Moderated 20
Alias Born 09/20/01
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2018 5:49:32 PM
Anavex Life Sciences to Present at the 2018 BIO CEO & Investor Conference GlobeNewswire Inc. - 2/8/2018 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/7/2018 5:05:16 PM
Anavex Life Sciences Provides Clinical Programs Update and Reports Fiscal First Quarter 2018 Financial Results GlobeNewswire Inc. - 2/7/2018 7:00:00 AM
Anavex Life Sciences to Announce Fiscal First Quarter 2018 Financial Results and Provide an Update on Clinical Programs and C... GlobeNewswire Inc. - 2/5/2018 7:00:00 AM
Anavex Life Sciences to Present at the Noble Capital Markets 14th Annual Institutional Investor Conference GlobeNewswire Inc. - 1/24/2018 7:00:00 AM
Anavex Life Sciences Reports Potential Normalization of Hypertension with ANAVEX®2-73 Published in The Journal of Clinical H... GlobeNewswire Inc. - 1/16/2018 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/15/2017 4:13:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/15/2017 4:11:28 PM
Annual Report (10-k) Edgar (US Regulatory) - 12/11/2017 5:17:35 PM
Anavex Life Sciences Reports Fiscal 2017 Financial Results And Provides Update On Therapeutic Programs GlobeNewswire Inc. - 12/11/2017 7:00:00 AM
Anavex Life Sciences Reports Newly Published Data on Alzheimer's Disease Research Demonstrate the Neuroprotective Features of... GlobeNewswire Inc. - 11/21/2017 7:00:00 AM
Anavex Life Sciences to Present at the 5th Annual Mental Health Parity Addiction Equity Act Business Roundtable in Washington... GlobeNewswire Inc. - 11/8/2017 7:00:00 AM
Anavex Life Sciences Presents New Clinical Data of Investigational Alzheimer’s Disease Treatment ANAVEX®2-73 at 2017 Clini... GlobeNewswire Inc. - 11/4/2017 3:30:00 PM
Greenbank Cap, Inc. (OTC Pink: GRNBF) Closes Private Placement as Shares Climb InvestorsHub NewsWire - 10/30/2017 7:00:00 AM
Anavex Life Sciences Announces Additional Data at The Michael J. Fox Foundation’s Parkinson's Disease Therapeutics Conferen... GlobeNewswire Inc. - 10/30/2017 7:00:00 AM
Anavex Life Sciences Announces New Data Related to Multiple Sclerosis Presented at 7th ECTRIMS-ACTRIMS Meeting MSPARIS2017 GlobeNewswire Inc. - 10/27/2017 8:52:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/26/2017 2:50:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/24/2017 12:06:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/19/2017 6:47:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/18/2017 9:47:41 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/16/2017 11:07:52 AM
Anavex Life Sciences Reports PK and PD Data from Phase 2a Trial of ANAVEX®2-73 in Mild-to-Moderate Alzheimer’s Disease Pat... GlobeNewswire Inc. - 10/12/2017 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/6/2017 5:18:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/5/2017 5:57:37 PM
XenaLives Member Level  Saturday, 08/12/17 09:40:42 PM
Re: A_Good_Day_2 post# 115267
Post # of 142257 
What you are asking about would require a new patent. The patent was for 2-73 and a specific amount of Donepezil. You are talking about a whole different can of worms.




In Peace, In War
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist